Showing results (61-70 of 96) with videos related to

Sort By:
Pageof 10
AIDS (London, England)|August 1, 1996
Resistance-related mutations in the HIV-1 protease gene of patients treated for 1 year with the protease inhibitor ritonavir (ABT-538)J C Schmit, L Ruiz, B Clotet, et al.
AIDS Research and Human Retroviruses|January 20, 1997
Cell type-dependent effect of sodium valproate on human immunodeficiency virus type 1 replication in vitroM Witvrouw, J C Schmit, B Van Remoortel, et al.
Scientific Reports|April 7, 2019
Tubulin is actively exported from the nucleus through the Exportin1/CRM1 pathwayK Schwarzerová, E Bellinvia, J Martinek, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|September 23, 2008
Viraemia and HIV-1 drug resistance mutations among patients receiving antiretroviral treatment in MozambiqueF Maldonado, M Biot, F Roman, et al.
HIV Medicine|November 30, 2005
Antiviral efficacy and resistance in patients on antiretroviral therapy in Kigali, Rwanda: the real-life situation in 2002A Fischer, J-C Karasi, D Kibibi, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|May 20, 2025
Retrospective analysis of different application methods in intratympanic glucocorticoid therapy for treatment of idiopathic SSNHL: A comparative outcome studyC Schmit, F Keller, T Gottfried, et al.
Antiviral Therapy|March 7, 2002
Genotypic correlates of resistance to HIV-1 protease inhibitors on longitudinal data: the role of secondary mutationsJ Servais, J M Plesséria, C Lambert, et al.
Journal of Virological Methods|March 1, 1995
Detection of HIV-1 RNA in plasma and serum samples using the NASBA amplification system compared to RNA-PCRA M Vandamme, S Van Dooren, W Kok, et al.
Journal of Clinical Microbiology|January 13, 2004
Simple DNA extraction method for dried blood spots and comparison of two PCR assays for diagnosis of vertical human immunodeficiency virus type 1 transmission in RwandaA Fischer, C Lejczak, C Lambert, et al.
Antimicrobial Agents and Chemotherapy|February 22, 2001
Variant human immunodeficiency virus type 1 proteases and response to combination therapy including a protease inhibitorJ Servais, C Lambert, E Fontaine, et al.
Pageof 10